Young children with HCM benefit from similar management strategies as older children: JACC Medha Baranwal8 Jun 2022 1:45 PM GMTUK: Early-onset childhood hypertrophic cardiomyopathy (HCM) (before 12 years) bears a similar symptom burden and cardiac phenotype compared to...
FDA approves mavacamten for managing symptomatic obstructive hypertrophic cardiomyopathy Dr. Kamal Kant Kohli2 May 2022 5:00 AM GMTThe US Food and Drug Administration has approved mavacamten (Camzyos) for treatment of symptomatic obstructive hypertrophic cardiomyopathy...
Mavacamten cuts need for invasive procedures in nearly 80% of HCM patients: VALOR-HCM Dr. Kamal Kant Kohli5 April 2022 3:30 AM GMTCleveland: Treatment with investigational mavacamten allowed patients with advanced obstructive hypertrophic cardiomyopathy (oHCM) to avoid septal...
Mavacamten in HOCM, is it good enough to replace older therapies? dr. Abhimanyu Uppal27 March 2021 5:45 AM GMTThe application of contemporary treatment strategies to hypertrophic cardiomyopathy (HCM) has transformed its prognosis from one of grim progression...
New medication may treat underlying causes of hypertrophic cardiomyopathy Hina Zahid11 March 2021 4:00 AM GMTDALLAS - The new, investigational heart medication mavacamten may improve key structural abnormalities of obstructive hypertrophic cardiomyopathy, a...
Hottest developments in the field of cardiology in 2020. Section 3: Heart failure dr. Abhimanyu Uppal25 Dec 2020 3:45 PM GMTInteresting developments have shown promise to improve the management of heart failure in 2020. From introducing the arrival of myosin inhibitors in...
2020 AHA/ACC Guideline for Diagnosis and Treatment of Hypertrophic Cardiomyopathy Hina Zahid29 Nov 2020 5:00 AM GMTThe American Heart Association and the American College of Cardiology have updated their guideline on managing hypertrophic cardiomyopathy (HCM).New ...
Mavacamten improves cardiac structure and function in HCM: Study Hina Zahid21 Nov 2020 2:53 AM GMTResearchers have found in a new study that mavacamten improves cardiac structure and function in hypertrophic cardiomyopathy.For the first time, a...
